SSR42 enhances the hemolytic capacity of Staphylococcus aureus by stabilizing the hla mRNA
Infection and Immunity · 10.11.2026
DOI: 10.1128/iai.00518-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection and Immunity, online erschienen am 10.11.2026. Verfasst von Mary-Elizabeth Jobson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biosciences, University of South Florida, Tampa, Florida, USA. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Staphylococcus aureus utilizes a complex regulatory network to precisely control a vast array of virulence factors and facilitate infection. One such regulator, the long regulatory RNA SSR42, is emerging as a key modulator of virulence factor abundance and pathogenesis. Previous work has shown that a primary role for SSR42 is controlling hemolytic behavior through the positive regulation of alpha-toxin ( hla /Hla). Herein, we confirm that loss of SSR42 limits hemolytic capacity due to reduced Hla production. Others have suggested that this occurs through the SaeRS two-component system; however, using epistasis experiments, we reveal that SSR42 and SaeRS function independently to control Hla activity. Using a two-plasmid system optimized to detect regulatory RNA-mediated control in gram-positive bacteria, we demonstrate that SSR42 directly enhances Hla production through the hla 5′ untranslated region. Using interaction prediction and targeted mutagenesis, we identify a discrete site upstream of the hla ribosome-binding site that is required for SSR42 binding and hemolytic activity. Transcriptional arrest experiments further show that SSR42 stabilizes the hla mRNA, increasing its half-life, and promoting downstream toxin production. Finally, electrophoretic mobility shift assays confirm a specific interaction between SSR42 and the hla 5′ UTR. Collectively, these findings establish SSR42 as a major post-transcriptional regulator of S. aureus virulence and reveal a novel RNA-mediated mechanism that promotes alpha-toxin production through stabilization of the hla transcript.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Biosciences, University of South Florida, Tampa, Florida, USA.
- Center for Antimicrobial Resistance, University of South Florida, Tampa, Florida, USA.
ORCID-Profile: Mary-Elizabeth Jobson, Lindsey N Shaw
Zitieren
APA
Jobson, M. E., Tomlinson, B. R., Jackson, J. K., & Shaw, L. N. (2026). SSR42 enhances the hemolytic capacity of Staphylococcus aureus by stabilizing the hla mRNA. Infection and Immunity. https://doi.org/10.1128/iai.00518-26
Vancouver
Jobson ME, Tomlinson BR, Jackson JK, Shaw LN. SSR42 enhances the hemolytic capacity of Staphylococcus aureus by stabilizing the hla mRNA. Infection and Immunity. 2026. doi:10.1128/iai.00518-26
BibTeX
@article{Jobson2026,
author = {Jobson, Mary-Elizabeth and Tomlinson, Brooke R and Jackson, Jessica K and Shaw, Lindsey N},
title = {SSR42 enhances the hemolytic capacity of Staphylococcus aureus by stabilizing the hla mRNA},
journal = {Infection and Immunity},
year = {2026},
doi = {10.1128/iai.00518-26}
}
EUVIMED